Kotak Reiterates Reduce (3) Rating on Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY)
Kotak analyst Alankar Garude reiterated a Reduce (3) rating and INR1,175.00 price target on Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)